Lanean...
Alpha‐lipoic acid for diabetic peripheral neuropathy
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of ALA as a disease‐modifying agent in DPN, looking at clinical indicators and biomarkers of disease (symptoms, neuropathy scores, ulceration, quality of life, and neurophysiological paramet...
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491199/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012967 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|